Form 4: Omnicell Executive Brian H. Nutt Reports Acquisition of Restricted Stock Units

Brian H. Nutt, VP and Chief Accounting Officer of Omnicell, Inc., reports the acquisition of 3,218 restricted stock units.

Summary

• On May 15, 2024, Brian H. Nutt, VP and Chief Accounting Officer of Omnicell, Inc., acquired 3,218 shares of common stock in the form of restricted stock units.
• These restricted stock units were granted under the company's equity incentive plan.
• 25% of the shares will vest on May 15, 2025, and the remaining 75% will vest quarterly over three years.
• Following the transaction, Nutt beneficially owns 3,218 shares of Omnicell common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices and aligns management interests with shareholders.

Positives

• The grant of restricted stock units aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The vesting schedule of the restricted stock units extends over three years, indicating a long-term incentive for the executive.

Industry Context

This is a standard practice for publicly traded companies to incentivize executives with equity-based compensation.

Comparison to Industry Standards

• Equity compensation is a common practice among publicly traded companies to align executive interests with shareholder value.
• Companies like Cerner (now Oracle Health) and McKesson also utilize stock options and restricted stock units as part of their executive compensation packages.
• The vesting schedules are generally in line with industry standards, typically ranging from three to five years.

Stakeholder Impact

• Shareholders may view this as a positive sign, indicating that the executive's interests are aligned with the company's long-term success.
• Employees may see this as a standard part of executive compensation.

Key Dates